BRK.B vs EXAS · rev $371.44B vs rev $2.76B
BRK.B (BRK.B) versus EXACT Sciences Corporation (EXAS) — a side-by-side from cached financials, not a winner call.
BRK.B (BRK.B) common stock. It is led by Warren Buffett.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Latest reported BRK.B revenue for 2025-12-31 was $371.44B. Net income was $66.97B. Revenue was up 616.8% from 2015-12-31 to 2025-12-31. BRK.B currently screens at market cap $0.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
BRK.B currently screens at market cap $0. EXAS currently screens at market cap $20.03B.
Not investment advice. Open the BRK.B and EXAS stock pages for the full models.
Not investment advice.